New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
09:45 EDTISIS, ISIS, BIIB, BIIBPiper Jaffray's biotech analyst holds an analyst/industry conference call
Analyst Schimmer discusses Isis Pharmaceuticals/Biogen's (ISIS/BIIB) SMNrx for Spinal Muscular Atrophy (SMA) on an Analyst/Industry conference call to be held on March 12 at 10 am.
News For ISIS;BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 15, 2015
07:29 EDTBIIBOutlook for Biogen trials positive , says RBC Capital
Subscribe for More Information
05:26 EDTISISIsis receives orphan status for myotonic dystrophy drug treatment
Subscribe for More Information
January 14, 2015
07:05 EDTBIIB, ISISIsis Pharmaceuticals earns $7M from Biogen for advancing muscular atrophy study
Subscribe for More Information
January 13, 2015
13:09 EDTBIIBBiogen CEO says company has strengthened R&D, to stay active in M&A
Subscribe for More Information
January 11, 2015
20:06 EDTBIIBBiogen acquires U.K.-based Convergence for up to $675M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use